Postoperative recurrence analysis of breast cancer patients based on clinical serum markers using discriminant methods

被引:18
作者
Li, Lu [1 ]
Gao, Qilong [1 ]
Xu, Guolin [2 ]
Shi, Bian [1 ]
Ma, Xuhui [1 ]
Liu, Huaimin [1 ]
Li, Qiujian [1 ]
Tian, Tongde [1 ]
Tang, Jingwen [1 ]
Niu, Hong [1 ]
机构
[1] Zhengzhou Univ, Affiliated Canc Hosp, Integrated TCM & Western Med Dept, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Canc Hosp, Inpatient Dept, Zhengzhou, Henan, Peoples R China
关键词
Breast cancer; serum marker; prognosis; diagnostic threshold value; SVM; CA; 15-3; CEA; ASSOCIATION; DIAGNOSIS; CA15-3; CA125;
D O I
10.3233/CBM-160322
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Breast cancer is a common gynecological malignant tumor and currently its clinical diagnosis mainly depends on methods of iconography and measurement of serum level. OBJECTIVE: To analyze correlation between serum index levels and prognosis of patients with breast cancer in one week and six months after operation, and to establish support vector machine (SVM) model to evaluate its effectiveness. METHODS: One hundred sixty eight patients diagnosed with breast cancer at Affiliated Cancer Hospital of Zhengzhou University were collected, 46 of which did palindromia while other 122 didn't six months after operation. Serum CA153, CA125 and CEA levels of different periods in two groups were analyzed from their differences. Through receiver operating characteristic (ROC) curve analysis, their diagnostic threshold values were calculated, at the same time, SVM model was built. RESULTS: There was a significant difference between serum index levels of recurrence group and non-recurrence group in one week and six months after operation (P < 0.05); SVM model was established with an accuracy of 96.67% (29/30), a sensitivity of 90% (9/10) and a specificity of 100% (20/20). CONCLUSIONS: Serum CAl53, CEA and CA125 levels after operation have certain instructional significance for prognosis of breast cancer patients, and the established SVM model has high clinical application value.
引用
收藏
页码:403 / 409
页数:7
相关论文
共 33 条
[11]  
Gao C., 2007, J RADIOIMMUNOL
[12]   Association of CA 15-3 and CEA with clinicopathological parameters in patients with metastatic breast cancer [J].
Geng, Biao ;
Liang, Man-Man ;
Ye, Xiao-Bing ;
Zhao, Wen-Ying .
MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (01) :232-236
[13]   Using ROC curves to test models of recognition memory: The relationship between presentation duration and slope [J].
Hirshman, E ;
Hostetter, M .
MEMORY & COGNITION, 2000, 28 (02) :161-166
[14]   Classification of fibroglandular tissue distribution in the breast based on radiotherapy planning CT [J].
Juneja, Prabhjot ;
Evans, Philip ;
Windridge, David ;
Harris, Emma .
BMC MEDICAL IMAGING, 2016, 16
[15]   Factors associated with mortality after breast cancer metastasis [J].
Jung, Su Yon ;
Rosenzweig, Margaret ;
Sereika, Susan M. ;
Linkov, Faina ;
Brufsky, Adam ;
Weissfeld, Joel L. .
CANCER CAUSES & CONTROL, 2012, 23 (01) :103-112
[16]   Cytokeratin19-2g2, a Novel Fragment of Cytokeratin19 in Serum, Indicating a More Invasive Behavior and Worse Prognosis in Breast Cancer Patients [J].
Kong, Yanan ;
Wang, Junye ;
Liu, Wanli ;
Chen, Qiaolun ;
Yang, Juan ;
Wei, Weidong ;
Wu, Mingqing ;
Yang, Lu ;
Xie, Xinhua ;
Lv, Ning ;
Guo, Jiaoli ;
Li, Laisheng ;
Gao, Jie ;
Xie, Xiaoming ;
Dai, Shuqin .
PLOS ONE, 2013, 8 (02)
[17]  
Kucera R, 2011, ANTICANCER RES, V31, P4653
[18]   Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer [J].
Lee, J. S. ;
Park, S. ;
Park, J. M. ;
Cho, J. H. ;
Kim, S. I. ;
Park, B-W .
ANNALS OF ONCOLOGY, 2013, 24 (05) :1225-1231
[19]  
Ouadagni F., 2001, CLIN CANCER RES, V7, P2357
[20]   Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer [J].
Pedersen, Ann Christina ;
Sorensen, Patricia Diana ;
Jacobsen, Erik Hugger ;
Madsen, Jonna Skov ;
Brandslund, Ivan .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2013, 51 (07) :1511-1519